Back
 
Name: Dr. Salman Khan
Designation: Associate Professor
Department: Pharmacy


Qualifications: PharmD (UOP), PhD (SNU, South Korea), Post Doc1 (SNU, South Korea), Post Doc2 (McGill Univ., Canada)


Phone: +92-51 9064-4056
Email: skhan@qau.edu.pk
Status: On Job
Other Weblink: https://scholar.google.com.pk/citations?hl=en&user=dfYfFCgAAAAJ&view_op=list_works&sortby=pubdate


Research Interests Publications Conferences Research Projects

Neuropharmacology & Analgesia, Immuno-Molecular Pharmacology, Biochemical-Systemic Pharmacology

RESEARCH STUDENTS GRADUATED

S.No

Student’s Name

PhD. Thesis title

Year

1.      

Bushra Shal

Pharmacological activities of Coagulansin-A, Bergenin and 1’S-1’-Acetoxychavicol acetate against neuroinflammation, aging and Alzheimer’s disease

August 24, 2022

2.      

Adnan Khan

Neuroprotective properties of Withametalin and Ajugarin-I against neuropathic pain and multiple sclerosis

July 21, 2022

3.      

Ashraf Ullah Khan

Anti-inflammatory and anti-cancer mechanism of N-(benzylidene)-2-((2-hydroxynaphthalen-1-yl) diazenyl) benzohydrazides (1–2) (NCHDH and NTHDH)

February 16, 2022

4.      

Sara Zeeshan

Pharmacological Mechanism of Synthetic Hydrazide Derivatives as Anti-inflammatory, Analgesic and Anti-epileptic Agents

March 28, 2022

5.      

Sidra Khalid

Studies on Pharmacological Mechanism underlying Antinociceptive and Anti-Neuroinflammatory Activities of Honokiol

April 21,2021

 

S.No

Student’s Name

M.Phil. Thesis title

Year

1.      

Raza Baqir

Pharmacological Effect of Matrine in Nitroglycerine-induced Migraine Model

May 23, 2023

2.      

Khudeja Idrees

Molecular Mechanism of ECN in Picryl chloride-induced Allergic Contact Dermatitis

May 23, 2023

3.      

Rabia Haider

Anti-Hyperalgesic Activities of Icariin in Post-Operative Pain Model

August 31, 2022

4.      

Sobia Aslam

Anti-Neuropathic Pain Property of Alantolactone in Paclitaxel-induced Mouse Model

August 31, 2022

5.      

M Ibrar Khan

Anti-nociceptive Effect of Magnolol in a Mouse model of postoperative pain

August 17, 2022

6.      

Sana Zafar

Pharmacological Evaluation of Daidzein in Mouse Model of Paclitaxel-Induced Neuropathic Pain

February 04, 2022

7.      

Zunaira Syed

Pharmacological Effects of Xanthoangelol on Scopolamine-induced Alzheimer’s Disease

January 05, 2022

8.      

Aqsa Azhar

Anti-depressant effect of zerumbone in animal model

October 29, 2021

9.      

Safa Amanat

Pharmacological Properties of Icariin in Cyclophosphamide-Induced Cystitis Pain

July, 2021

10.   

Tehmina Bibi

Pharmacological effects of Magnolol in animal model of Multiple Sclerosis

July 07, 2020

11.   

Younas

Anti-Allergic Activity of Umbelliferone in rodents

Jun 30, 2020

12.   

Farah Naz

Attenuation of Glycerol-Induced Nephrotoxicity by Structurally Modified Platinum

October 23, 2019

13.   

Zartashia Kazmi

Anti-epileptic activity of Daidzin in PTZ-induced Mice Model

October 15, 2019

14.   

Amna Khan

Anti-inflammatory and anti-nociceptive activities of 7β-(3-ethylcis-crotonoyloxy)-1α-(2-methylbutyryloxy)-3,14-dehydro-Z-notonipetranone (ECN) in rodents

October 08, 2019

15.   

Amir Muhammad

Nephroprotective Effects of Continentalic Acid in LPS-induced Acute Kidney Injury

October 03, 2019

16.   

Hassan Ali

Attenuation of LPS-induced Acute Lung Injury by Continentalic Acid in Rodents

May 06, 2019

17.   

Hadayatullah

Hepatoprotective Effects of Poncirin Induced by CCl4- and Paracetamol in Animal Models

May 06, 2019

18.   

Jawad Ali

Mucoprotective Effects of Saikosaponin-A in 5-Flourouracil-Induced Intestinal Mucositis in Mice Model

May 06, 2019

19.   

Ayesha Atiq

Diadzein attenuates 5-Flourouracil-induced intestinal mucositis by suppressing inflammatory mediators in rodents

October 10, 2018

20.   

Bushra Shal

Anti-anxiety and anti-depressant activities of 25-Methoxyhispidol A in mice

September 10, 2018

21.   

Adnan Khan

Pharmacological evaluation of matrine in animal models of anxiety and depression

September 07, 2018

22.   

M Naveed

Anti-inflammatory, anti-nociceptive and anti-pyretic activities of newly synthesized (4-benzylpiperidine-1-carbodithioato-κ2S,Sʹ)(1,4-bis-(diphenylphosphino)butane) palladium (II) chloride monohydrate (BCDP) in in vivo pharmacological models

September 06, 2018

23.   

Zia ullah

Attenuation of inflammatory pain by puerarin in animal model of inflammation

May 10, 2018

24.   

Hina Rasheed

Anti-Rheumatic activity of 2(5-mercapto-1,3,4oxadiazol-2yl)-N-propylbenzenesulphonamide in CFA-induced arthritis models

March 02, 2018

25.   

Ruqayya Afridi

1.      Evaluation of analgesic activities of poncirin in invivo animal models and computational approach for identification of specific target

Feb 22, 2018

26.   

Ashrafullah Khan

Pharmacological evaluation of 25-MHA underlying anti-nociceptive properties in animal models

Feb 06, 2018

27.   

Ayesha Inam

Knowledge and attitude towards evidence-based practice: A comparative study between physicians and pharmacists

Sep 14, 2017

28.   

Maria Tanveer

Pharmaceutical practice approach toward epilepsy management

Sep 14, 2017

29.   

Faiza Shahid

Assessment of clinical outcomes and quality of life in burn patients

Feb 13, 2017

30.   

M Ammar Zahid

Evaluation of pharmacological activities of 1,3,4 Oxadiazole derivatives

Jun 21, 2016

 

RESEARCH/REVIEW PUBLICATIONS (SCI/IF)

 

Author (s), title

Journal, Vol. No., Page No., Country

Year

Impact factor

1.     T Bibi, S Bano, F Din, H Ali, Salman Khan. “Preparation, characterization, and pharmacological application of oral Honokiol-loaded solid lipid nanoparticles for diabetic neuropathy”.

International Journal of Pharmaceutics, 645, 123399

2023

5.8

2.     M W Akram, D Mazhar, I Afzal, A Zeb, "Q Ul Ain" , "Salman Khan. Design and Evaluation of Continentalic Acid Encapsulated Transfersomal Gel and Profiling of its Anti-Arthritis Activity

AAPS PharmSciTech

AAPSPT-D-23-00538R1

 

ACCEPTED

2023

4.3

3.     K Nousheen, F U Din, H Janshaid, R Afza,  S Ullah Khan, M Malik, Z Ali, S Batool, A Zeb, AM Yousaf, AH Almari, S Alqahtani, Salman Khan, GM Khan.  Metformin HCl-loaded transethosomal gel; Development, characterization, and antidiabetic potential evaluation in the diabetes-induced rat model

Drug Delivery

 

Drug Delivery

VOl. 30, NO. 1, 2251720

2023

6.0

4.     M Zeeshan, Qu Ain, A Sunny, FRaza, MMohsin, Salman Khan, BWeigmannd and H Ali. QbD-based fabrication of transferrin-anchored nanocarriers for targeted drug delivery to macrophages and colon cells for mucosal inflammation healing

Biomaterials Science 11,

1373

2023

7.5

5.     Danish Mazhar, Naveed Ul Haq, Mahira Zeeshan, Qurat Ul Ain, Hussain Ali, Salman Khan, Saeed Ahmad Khan. Preparation, characterization, and pharmacokinetic assessment of metformin HCl loaded transfersomes co-equipped with permeation enhancer to improve drug bioavailability via transdermal route.

Journal of Drug Delivery Science and Technology

Volume 84, 104448

June 2023

5.06

6.     S Zafar, Y Luo, L Zhang, CH Li, A Khan, MI Khan, K Shah, EK Seo, F Wang, Salman Khan. Daidzein attenuated paclitaxel-induced neuropathic pain via the down-regulation of TRPV1/P2Y and up-regulation of Nrf2/HO-1 signaling

Inflammopharmacology 31, 1977–1992

 

2023

5.093

7.     D Mazhar, N Haq, M Zeeshan, Q Ain, H Ali, Salman Khan, SAKhan. Preparation, characterization, and pharmacokinetic assessment of metformin HCl loaded transfersomes co-equipped with permeation enhancer to improve drug bioavailability via transdermal route

Journal of Drug Delivery Science and Technology, 104448

2023

5.062

8.      AKhan, B Shal, A Khan, MW Baig, I Haq, Salman Khan. Withametelin, a steroidal lactone, isolated from datura innoxa attenuates STZ-induced diabetic neuropathic pain in rats through inhibition of NF-kB/MAPK signaling

Food and Chemical Toxicology 175 (2023) 113742

2023

5.572

9.     A Khan, A Khan, B Shal, Salman Khan, M Khan, R Ahmad, M Riaz. The critical role of the phytosterols in modulating tumor microenvironment via multiple signaling: A comprehensive molecular approach

Phytotherapy Research.37:1606–1623

2023

6.388

10.  A Khan, B Shal, A Khan, K Shah2, SS Zahra, I Haq, F Din, HAli, Salman Khan. Neuroprotective Mechanism of Ajugarin-I Against Vincristine-Induced Neuropathic Pain via Regulation of Nrf2/NF-kB and Bcl2 Signalling

International Immunopharmacology 118 (2023) 110046

2023

5.714

11.  A Khan, B Shal, A Khan, T Bibi, S Zeeshan, Syeda S Zahra, P Crews, I Haq, F Din, H Ali, Salman Khan.  Suppression of MAPK/NF-kB and activation of Nrf2 signaling by Ajugarin-I in EAE model of multiple sclerosis. (*Corresponding author)

Phytotherapy Research

37(6):2326-2343

2023

6.388

12.  H Jamshaid, F Din, K Nousheen, S Khan, A Fatim, Salman Khan, HG Choi, GM Khan. Mannosylated imiquimod-terbinafine co-loaded transethosomes for cutaneous leishmaniasis; assessment of its anti-leishmanial potential, in vivo safety and immune response modulation. (*Co-author)

Biomaterials Advances

Vol 145, 213266

2023

4.727

13.  M Zeeshan, Q Ain, A Sunny, F Raza, M Mohsin, Salman Khan, B Weigmann and H Ali.  QbD-based fabrication of transferrin-anchored nanocarriers for targeted drug delivery to macrophages and colon cells for mucosal inflammation healing. (*Co-author)

Biomaterial Sciences

https://doi.org/10.1039/D2BM01719A

 

 

2023

7.59

14.  MM Khan, SSZaidi, FJ Siyal, S Khan, G Ishrat, S Batool, O Mustapha, Salman Khan, F Din. Statistical optimization of co-loaded rifampicin and pentamidine polymeric nanoparticles for the treatment of cutaneous leishmaniasis. (*Co-author)

Journal of Drug Delivery Science and Technology, (79), 104005

2023

5.062

15.  MI Khan, A khan, S Zafar, S Aslam, A Khan, B Shal, R Haider, F Din and Salman Khan. Anti-nociceptive effects of magnolol via inhibition of TRPV1/P2Y and TLR4/NF-κB signaling in a postoperative pain model. (*Corresponding author)

Life Sciences

(312), 121202

 

2023

6.780

16.  S Maqsood, F Din, S Khan, E Elahi, Z Ali, H Jamshaid, A Zeb, TNadeem, W Ahmed, Salman Khan, HG Choi. Levosulpride-loaded nanostructured lipid carriers for brain delivery with antipsychotic and antidepressant effect. (*Co-author)

Life Sciences

311 (Part B), 121198

2022

6.780

17.  H Khalid, S Batool, F Din, Salman Khan*, GM Khan. Macrophage Targeting of Nitazoxanide-Loaded Transethosomal Gel in Cutaneous Leishmaniasis. (*Co-author)

Royal Society Open Science

9:

220428.

2022

2.99

18.  A Khan, F Wang, B Shal, A Khan, SS Zahra, I Haq, Salman Khan*, K Rengasamy. Anti-neuropathic pain activity of Ajugarin-I via activation of Nrf2 signaling and inhibition of TRPV1/TRPM8 nociceptors in STZ-induced diabetic neuropathy (*Corresponding author)

Pharmacological Research

Vol 183, 106392

2022

10.33

19.  S Hassan, A Shehzad, SA Khan, W Miran, Salman Khan*, YS Lee. Diagnostic and therapeutic potential of circulating-free DNA and cell free RNA in cancer management. (*Co-author)

Biomedicines- 22;10(8):2047

2022

4.75

20.  F Zahid, S Batool, Z Ali, Abdul Nabi, Salman Khan*, O Salman, GM Khan. Antileishmanial agents co-loaded in transfersomes with enhanced macrophage uptake and reduced toxicity.  (*Co-author)

AAPS Pharm Sci Tech

16;23(6):226.

 

2022

4.0

21.  A Khan, S Khan, A Khan, B Shal, S Rehman, S Rehman, T Htar, Salman Khan*, S Anwar, A Alafnan, KRR Rengasamy. Anti-inflammatory and anti-rheumatic potential of selective plants compounds by targeting TLR-4/AP-1 signaling: A comprehensive molecular docking and simulation approaches. (*Corresponding author)

Molecules 27, 4319

2022

4.927

22.  A Basit, T Shutian, A Khan, SM Khan, R Shahzad, A Khan, Salman Khan*, M Khan. Anti-inflammatory and analgesic potential of leaf extract of Justicia adhatoda L. (Acanthaceae) in Carrageenan and Formalin-induced models by targeting oxidative stress (*Co-author)

Biomedicine & Pharmacotherapy

Volume 153, 113322

2022

7.419

23.  M Rehman, S Ghazanfar, R Haq, S Ullah, Salman Khan*, J Wu, W Ahmad and MK Tipu. Probiotics (Bacillus clausii and Lactobacillus fermentum NMCC-14) ameliorate stressed behavior in mice by increasing monoamines level and mRNA expression of dopamine receptors (D1 and D2) and synaptophysin. (*Co-author)

Frontiers in Pharmacology, Volume 13, 915595

2022

5.988

24.  B Shal, A Khan, A Khan, R Ullah, M Naveed, G Ali, S Islam, I Haq, B Mirza, Salman Khan*. Coagulansin-A improves spatial memory in 5xFAD Tg mice by targeting Nrf- 2/NF-κB and Bcl-2 pathway.  (*Corresponding author)

International Immunopharmacology, 108860

2022

5.714

25.  B Shal, S Amanat, A Khan, YJ Lee, H Ali, F Ud-Din, Y Park, Salman Khan. Potential applications of PEGylated green gold nanoparticles in cyclophosphamide-induced cystitis. (*Corresponding author)

Artificial Cells, Nanomedicine, and Biotechnology

50 (1), 130–146

2022

6.355

26.  Z Syed, B Shal, A Azha, S Amanat, A Khan, H Ali, YS Kim, EK Seo, Salman Khan*. Pharmacological mechanism of xanthoangelol underlying Nrf-2/TRPV1 andmanti-apoptotic pathway against scopolamine-induced amnesia in mice. (*Corresponding author)

Biomedicine & Pharmacotherapy,

150, 113073

2022

7.419

27.  A Khan, A Khan, B Shal, A Aziz, MN Ahmed, Salman Khan*. N-(benzylidene)-2-((2-hydroxynaphthalen-1-yl)diazenyl)benzohydrazides (1-2) (NCHDH and NTHDH) attenuates DMBA-induced breast cancer via Nrf2/NF-κB/apoptosis signaling. (*Corresponding author)

Fundamental & Clinical Pharmacology

36(5):879-897

2022

2.747

28.  S Amanat, B Shal, EK Seo, H Ali, Salman Khan*. Icariin attenuates cyclophosphamide-induced cystitis via down-regulation of NF-kB and up-regulation of Nrf-2/HO-1 signaling pathways in mice model. (*Corresponding author)

International Immunopharmacology 106, 108604

https://doi.org/10.1016/j.intimp.2022.108604.

 

2022

5.714

29.  H Ullah, A Khan, T Bibi, S Ahmad, O Shehzad, H Ali, EK Seo, Salman Khan*. Comprehensive in vivo and in silico approaches to explore the hepatoprotective Activity of poncirin against the paracetamol toxicity. (*Corresponding author)

Naunyn-Schmiedeberg’s Archives of Pharmacology, 395(2):195-215

https://doi.org/10.1007/s00210-021-02192-1

 

2022

3.125

30.  A Khan, B Shal, AU Khan, T Bibi, S Islam, MW Baig, I Haq, H Ali, S Ahmad, Salman Khan*. Withametelin, a novel phytosterol, alleviates neurological symptoms in EAE mouse model of multiple sclerosis via modulation of Nrf2/HO-1 and TLR4/NF-κB signaling. (*Corresponding author)

Neurochemistry International

105211

https://doi.org/10.1016/j.neuint.2021.105211

October 2021

4.297

31.  M Naveed, SZ Khan, R Ullah, A Khan, B Shal, A Khan, Z Rehman, Salman Khan*. Anti-neuropathic pain activity of a cationic palladium (II) dithiocarbamate by suppressing the inflammatory mediators in paclitaxel-induced neuropathic pain model. (*Corresponding author)

Molecular Biology Reports, 48(12):7647-7656

https://doi.org/10.1007/s11033-021-06754-7

2021

2.742

32.  M Zeeshan, A Atiq, Q Ain, J Ali, Salman Khan*, H Ali. Evaluating the mucoprotective efects of glycyrrhizic acid‑loaded polymeric nanoparticles in a murine model of 5‑fuorouracil‑induced intestinal mucositis via suppression of infammatory mediators and oxidative stress. (*Co-author)

Inflammopharmacology (2021). 29(5):1539-1553

2021

5.093

33.  Y, A Khan, O Shehzad; EK Seo, A Onder, Salman Khan*. Anti-allergic activities of Umbelliferone against Histamine and Picryl chloride-induced ear edema by targeting Nrf2/iNOS signaling in mice. (*Corresponding author)

BMC Complementary Medicine and Therapies 21:215

https://doi.org/10.1186/s12906-021-03384-1

2021

2.838

34.  B Shal, A Khan, A Khan, R Ullah, GAli, S Islam, I Haq, H Ali, E-K Seo, and Salman Khan*. Alleviation of Memory Deficit by Bergenin via the Regulation of Reelin and Nrf-2/NF-κB Pathway in Transgenic Mouse Model. (*Corresponding author)

International Journal of Molecular Sciences

22, 6603. https://doi.org/10.3390/ijms22126603

2021

6.208

35.  A Khan, B Shal, A Khan, R Ullah, M W Baig, I Haq, EK Seo, Salman Khan*. Suppression of TRPV1/TRPM8/P2Y nociceptors by withametelin via downregulating MAPK signaling in mouse model of vincristine-induced neuropathic pain. (*Corresponding author)

International Journal of Molecular Sciences 22(11), 6084; https://doi.org/10.3390/ijms22116084  

2021

6.208

36.  M Zeeshan, H Ali, Q Ain, M Mukhtar, R Gul, A Sarwar, Salman Khan*. A holistic QBD approach to design galactose conjugated PLGA polymer and nanoparticles to catch macrophages during intestinal inflammation. (*Co-author)

Materials Science and Engineering: C, Vol 126, 112183

2021

8.457

37.  E Sana, M Zeeshan, Q Ain, A Khan, I Hussain, Salman Khan*, E Lepeltier & H Ali. Topical delivery of curcumin-loaded transfersomes gel ameliorated rheumatoid arthritis by inhibiting NF-κβ pathway (*Co-author)

Nanomedicine (Lond.) 126:112183. doi:10.1016/j.msec.2021.112183.

 

2021

7.033

38.  F Rehman, K Mazhar, A Malik, SS Naz, K Ullah Shah, A Khan, Salman Khan*, R Ahmed, S Qaisar. Surface multifaceted nanocarriers for oral non-conventional cancer therapy; synthesis and evaluation. (*Co-author)

Materials Science and Engineering: C,

Vol 123, 111940

April 2021

8.457

39.  A Shehzad, SU Islam, R Shahzad, Salman Khan*, YS Lee. Extracellular vesicles in cancer diagnostics and therapeutics. (*Co-author)

Pharmacology & Therapeutics

Vol 223, 107806

July, 2021

13.400

40.  SZ Khan, Z Khan, I Ahmad, S Khan, Salman Khan*, M Ahmad, M Inam, F B-Gariepy, Z Rehman. Structural Features, Anticancer, Antioxidant and Anti-acetylcholinesterase Studies of [(DTCs)(PAr3)PdCl]. (*Co-author)

Inorganic Chemistry Communications 123,

108316

January 2021

3.428

41.  A Khan, A Khan, S Khalid, B Shal, E Kang, H Lee, G Laumet, EK Seo, Salman Khan*. 7β-(3-ethyl-cis-crotonoyloxy)-1α-(2-methylbutyryloxy)-3,14-dehydro-Z Notonipetranone Attenuates Neuropathic Pain by Suppressing Oxidative Stress, Inflammatory and Pro-Apoptotic Proteins Expression. (*Corresponding author)

Molecules. 1;26(1):181

 

January, 2021

4.927

42.  H Ali, A Khan, J Ali, H Ullah, A Khan, H Ali, N Irshad and Salman Khan*. Attenuation of LPS-induced acute lung injury by continentalic acid in rodents through inhibition of inflammatory mediators correlates with increased Nrf2 protein expression. (*Corresponding author)

BMC Pharmacology and Toxicology 21(1):81

DOI: 10.1186/s40360-020-00458-7

November 2020

2.605

43.  AU Khan, A Muhammad, A Khan, B Shal, A Aziz, MN Ahmed, Salman Khan*. The newly synthesized compounds (NCHDH and NTHDH) attenuate LPS-induced septicemia and multi-organ failure via Nrf2/HO1 and HSP/TRVP1 signaling in mice. (*Corresponding author)

Chemico-Biological Interactions

Volume 329, 25, 109220

September 2020

5.168

44.  M Mukhtar, M Zeeshan, Salman Khan*, G Shahnaz, SA Khan, HS Sarwar, RA Pasha & H Ali. Fabrication and optimization of pH sensitive mannose-anchored nano-vehicle as a promising approach for macrophage uptake. (*Co-author)

Applied Nanoscience 10:4013–4027

2020

3.869

45.  Z Kazmi, S Zeeshan, A Khan, S Malik, A Shehzad, EK Seo, Salman Khan*. Anti-epileptic activity of daidzin in PTZ-induced mice model by targeting oxidative stress and BDNF/VEGF signalling. (*Corresponding author)

Neurotoxicology 79, 150-163

 

 

2020

4.398

46.  A Khan, B Shal, M Naveed, B Nasir, N Irshad, H Ali, and Salman Khan*. Matrine alleviates neurobehavioral alterations via modulation of JNK-mediated caspase-3 and BDNF/VEGF signaling in a mouse model of burn injury. (*Corresponding author)

Psychopharmacology

Psychopharmacology (Berl), 237(8):2327-2343

August, 2020

8.294

47.  B Shal, A Khan, M Naveed, H Ali, H Choi, EK Seo, Salman Khan*. Neuroprotective effect of 25-Methoxyhispidol A against CCl4-induced behavioral alterations by targeting VEGF/BDNF and caspase-3 in mice. (*Corresponding author)

Life Sciences 

Volume 253, 15 July 2020, 117684

July, 2020

6.780

48.  H Ullah, A Khan, MW Baig, N Ullah, N Ahmed; M K Tipu, H Ali, Salman Khan*. Poncirin attenuates CCL-4-induced liver injury through inhibition of oxidative stress and inflammatory cytokines in mice. (*Corresponding author)

BMC-Complementary Medicine and Therapy, 20:115

DOI: 10.1186/s12906-020-02906-7

April, 2020

2.838

49.  M Qindeel, D Khan, N Ahmed, Salman Khan*, A Rehman. Surfactant free, self-assembled nanomicelles-based transdermal hydrogel for safe and targeted delivery of methotrexate against rheumatoid arthritis. (*Co-author)

ACS NANO

28;14(4):4662-4681.

 

March, 2020

18.027

50.  AM Khan, A Khan, H Ali, S Islam, EK Seo, Salman Khan*Continentalic Acid Exhibited Nephroprotective Activity Against the LPS and E. Coli-Induced Kidney Injury Through Inhibition of the Oxidative Stress and Inflammation. (*Corresponding author)

International Immunopharmacology

80, 106209

March, 2020

5.714

51.  D Khan, M Qindeel, N Ahmed, A Khan1, Salman Khan* and A Rehman. Development of novel pH-sensitive nanoparticle-based transdermal patch for management of rheumatoid arthritis. (*Co-author)

Nanomedicine (London)

15(6):603-624.

Feb, 2020

7.033

52.  J Ali, A Khan, FA Shah, H Ali, S Islam, YS Kim and Salman Khan*. Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model. (*Corresponding author)

Life Sciences 19; 239:116888.

2019

6.780

53.  N Shah, T Zaman, T Rehan, Salman Khan*, W Khan, A Khan, MU Islam. Preparation and Characterization of Agar Based Magnetic Nanocomposite for Potential Biomedical Applications. (*Co-author)

Current Pharmaceutical Design. 25(34):3672-3680.

Oct 11, 2019.

3.310

54.  Q Ain, M Zeeshan, Salman Khan*, H Ali. Biomimetic hydroxyapatite as potential polymeric nanocarrier for the treatment of rheumatoid arthritis. (*Co-author)

Journal of Biomedical Materials Research - Part A

107(12):2595-2600.

August 2019

4.854

55.  S Khalid, A Khan, B Shal, H Ali, YS Kim, Salman Khan*. Suppression of TRPV1 and P2Y nociceptors by honokiol isolated from Magnolia officinalis in 3rd degree burn mice by inhibiting inflammatory mediators. (*Corresponding author)

Biomedicine & Pharmacotherapy

Volume 114, 108777

June, 2019

7.419

56.  A Khan, Salman Khan*, H Ali, K Shah, H Ali, O Shehzad, A Onder, YS Kim. Anomalin attenuates LPS-induced acute lungs injury through inhibition of AP-1 signaling. (*Corresponding author and 1st author)

International Immunopharmacology 73 (2019) 451–460

USA

May, 2019

5.714

 

57.  S Zeeshan, M Naveed, A Khan, A Atiq, M Arif, MN Ahmed, YS Kim, Salman Khan*. N-Pyrazoloyl and N-thiopheneacetyl hydrazone of isatin exhibited potent anti-inlammatory and anti-nociceptive properties through suppression of NF-κB, MAPK and oxidative stress signaling in animal models of inflammation. (*Corresponding author)

Inflammation Research 68:613–632

Canada

May 2019

6.986

58.  M Saqlain, A Riaz, MN Malik, Salman Khan*, Al Ahmed, S Kamran, H Ali. Medication adherence and its association with health literacy and performance in activities of daily livings among elderly hypertensive patients. (*Co-author)

Medicina 55, 163; doi:10.3390/medicina55050163

Republic of Lithuania

May 2019

2.244

59.  M Zeeshan, H Ali, M Arshad, M Ijaz Khan, M Mukhtar, Salman Khan*. Glycyrrhizic acid loaded pH-sensitive PLGA nanoparticles for the amelioration of inflammatory bowel disease. (*Co-author)

Nanomedicine Vol 14(15), 1945–1969)

2019

7.033

60.  B Shal, A Khan, M Naveed, N Khan, I Haq, SD Al-Sharari, YS Kim, Salman Khan*Effect of 25-methoxy hispidol A isolated from Poncirus trifoliate against bacteria-induced anxiety and depression by targeting neuroinflammation, oxidative stress and apoptosis in mice. (*Corresponding author)

Biomedicine & Pharmacotherapy

111, 209-223. USA

March, 2019

7.419

61.  M Zeeshan, H Ali, Salman Khan*, SA Khan, B Weigmann. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease.  (*Co-author)

International Journal of Pharmaceutics. 10; 558:201-214. France

March, 2019

6.510

62.  A Khan, B Shal, M Naveed, FA Shah, A Atiq, N Ullah Khan, YS Kim, Salman Khan*. Matrine ameliorates anxiety and depression-like behaviour by targeting hyperammonemia-induced neuroinflammation and oxidative stress in CCl4 model of liver injury. (*Corresponding author)

Neurotoxicology. 8; 72:38-50.  USA

February, 2019

4.398

63.  A Khan, M Zia Ullah, R Afridi, H Rasheed, S Khalid, H Ullah, H Ali, S AlSharari, Y S Kim, Salman Khan*. Antinociceptive properties of 25‐methoxy hispidol A, a triterpinoid isolated from Poncirus trifoliata (Rutaceae) through inhibition of NF‐κB signalling in mice. (*Corresponding author)

Phytotherapy Research. 2019; 33:327–341. USA

February, 2019

6.388

64.  A Khan, Salman Khan, YS Kim. Insight of Pain modulation: nociceptors sensitization and therapeutic targets. (*Corresponding author)

Current Drug Targets.

20(7):775-788.

January 30, 2019

2.937

65.  A Atiq, B Shal, M Naveed, A Khan, J Ali, S Zeeshan. SD. Al-Sharari, YS Kim, Salman Khan*. Diadzein ameliorates 5-fluorouracil-induced intestinal mucositis by suppressing oxidative stress and inflammatory mediators in rodents. (*Corresponding author)

European Journal of Pharmacology, 843, 15, 292-306

Netherland

January 2019

5.195

66.  S Khalid, MA Zahid, H Ali, YS Kim, Salman Khan*. Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer’s disease. (*Corresponding author)

BMC Neuroscience 13;19(1):74.

November, 2018

3.264

67.  M Zia ullah, A Khan, R Afridi, H Rasheed, S Khalid, M Naveed, H Ali YS Kim, Salman Khan*. Attenuation of inflammatory pain by Puerarin in animal model of inflammation through inhibition of pro-inflammatory mediators. (*Corresponding author)

International Immunopharmacology-61:306-316 (USA)

2018

5.714

 

68.  H Rasheed, R Afridi, A Khan, M Z Ullah, S Khalid, A Atiq, H Kashif, M Naeem Ahmed, Y S Kim, Salman Khan*. Anti-inflammatory, anti-rheumatic and analgesic activities of 2-(5-mercapto-1,3,4-oxadiazol-2-yl)-N-propylbenzenesulphonamide (MOPBS) in rodents. (*Corresponding author)

Inflammopharmacology; 26:1037–1049. (UK)

2018

5.093

69.  B Shal, W Ding, H Ali, YS Kim, Salman Khan*. Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer’s disease. (*Corresponding author)

 

Frontiers in Pharmacology- 9, Article 548. doi: 10.3389/fphar.2018.00548(Switzerland).

2018

5.988

70.  S Khalid, M Z. Ullah, A Khan, R Afridi, H Rasheed, A Khan, H Ali, YS Kim, and Salman Khan*. Antihyperalgesic Properties of Honokiol in Inflammatory Pain Models by Targeting of NF-κB and Nrf2 Signaling. (*Corresponding author)

 

Frontiers in Pharmacology, Vol 09 /article-140. doi: 10.3389/fphar.2018.00140(Switzerland)

2018

5.988

71.  Salman Khan*, RJ Choi, JH Lee, YS Kim. Attenuation of neuropathic pain and neuroinflammatory responses by a pyranocoumarin derivative in animal and cellular models. (*Corresponding author)

 

European Journal of Pharmacology 774, 95–104. (Netherland)

2016

5.195

72.  Salman Khan*, O Shehzad, R Li, MS Cheng, and YS Kim. Pharmacological mechanism underlying anti-inflammatory properties of two structurally divergent coumarins through inhibition of pro-inflammatory enzymes and cytokines. (*1st author)

 

Journal of Inflammation, 29; 12:47. (UK)

2015

6.283

73.  Salman Khan*, O. Shehzad, J. Chun, R, J. Choi, M. N. Islam, J. S. Choi, and Y. S. Kim. Anti-hyperalgesic and anti-allodynic activities of capillarisin via suppression of inflammatory signaling in animal model. (*1st author)

 

Journal of Ethnopharmacology, 28;152(3):478-86). (Netherland)

2014

5.195

74.  Salman Khan*, O. Shehzad, K. J. Lee, A. Tosun, Y. S. Kim Anti-inflammatory properties of samidin from Sesli resinosm though suppression of NF-κB and AP-1-mediated-genes in LPS-stimulated RAW 264.7 cells. (*1st author)

 

Archive of Pharmacal Research, 37(11):1496-503. (South Korea)

2014

6.010

75.  R. J Choi, J. Chun, Salman Khan* and Y. S. Kim. Desoxyrhapontigenin, a potent anti-inflammatory phytochemical, inhibits LPS-induced inflammatory responses via suppressing NF-κB and MAPK pathways in RAW 264.7 cells. (*Co-author)

International Immunopharmacology, 18,182–190. (USA)

2014

5.714

 

76.  A Tosun, Salman Khan*, YS Kim, á Calín-Sánchez, X Hysenaj and Aá Carbonell-Barrachina. I Essential Oil Composition and Anti-Inflammatory Activity of Salvia officinalis L (Lamiaceae) in Murin Macrophages. (*Co- author)

Tropical Journal of Pharmaceutical Research, 13 (6): 937-942. (Africa).

2014

0.523

77.  Salman Khan*, O. Shehzad, J. Chun, Y. S. Kim Mechanism underlying anti-hyperalgesic and anti-allodynic properties of anomalin in both acute and chronic inflammatory pain models in mice through inhibition of NF-κB, MAPKs and CREB signaling cascades. (*1st author)

European Journal of Pharmacology, 718, 448–458. (Netherland)

2013

5.195

78.  Salman Khan*, R. J. Choi, O. Shehzad, H. P. Kim, M. N. Islam, J. S. Choi, and Y. S. Kim. Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signals in in vitro and in vivo experimental models. (*1st author)

 

Journal of Ethnopharmacology, 145, 626–637. (Netherland)

2013

5.195

79.  O. Shehzad, Salman Khan*, I.J.  Ha, Y. Park, A. Tosun, Y. S. Kim.Application of stepwise gradients in counter-current chromatography: A rapid and economical strategy for the one-step separation of eight coumarins from Seseli resinosum(*Co-author)

Journal of Chromatography A, 1310 66–73. (USA)

2013

4.601

80.  R. J. Choi, T. M. Ngoc, K. Bae, H. J. Cho, D. D. Kim, J. Chun, Salman Khan*, Y. S. Kim.  Anti-inflammatory properties of anthraquinones and their relationship with the regulation of P-glycoprotein function and expression. (*Co-author)

 

European Journal of Pharmaceutical Sciences, 48, 272–281. (Netherland)

2013

5.589

81.  Salman Khan*, O. Shehzad, E. R. Woo, S. S. Kang, S. W. Baek, J. Kim, Y. S. Kim. Anti-inflammatory Mechanism of 15,16-Epoxy-3α-hydroxylabda-8,13(16),14-trien-7-one via Inhibition of LPS-Induced Multicellular Signaling Pathways. (*1st author)

 

Journal of Natural Products, 75, 67−71. (USA)

2012

4.803

82.  J. Chun, R. J. Choi, Salman Khan*, D. S. Lee, Y.C Kim, Y. J Nam, D. U Lee, Y. S. Kim. Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells. (*Co-author)

International Immunopharmacology, 14(4):375-83. (USA)

2012

 5.714

 

83.  O. Shehzad, Salman Khan*, I. J. Ha, Y. Park, Y. S. Kim. Rational development of a selection model for solvent gradients in single-step separation of ginsenosides from Panax ginseng using high-speed counter-current chromatography. (*Co-author)

 

Journal of Separation Science, 35, 1462–1469. (USA)

2012

3.614

84.  Shehzad, Salman Khan*, Y. S Lee. Curcumin molecular targets in obesity and obesity related cancer. (*Co-author)

 

Future Oncology, 8(2), 1-12.  (USA)

2012

3.674

85.  Salman Khan*, E. M. Shin, Y. H. Jung, J. Kim, A. Tosun, Y. S. Kim. Suppression of LPS-induced inflammatory and NF-κB responses by anomalin in RAW 264.7 macrophages. (*1st author)

 

Journal of Cellular Biochemistry, 112(8):2179-88. (USA)

2011

4.480

86.  O. Shehzad, Salman Khan*, T. Khan and JK Park. Physicochemical and mechanical characterization of bacterial cellulose produced with an excellent productivity in static conditions using a simple fed-batch cultivation strategy. (*Co-author)

 

Carbohydrate Polymers, 82, 173-180. (USA)

2010

10.723

87.  Shehzad, Salman Khan*, O. Shehzad, and Y. S. Lee. Curcumin therapeutic promises and bioavailability in colorectal cancer. (*Co-author)

 

Drugs of Today, 46(7): 523. (Spain)

2010

2.436

88.  O. Shehzad, Salman Khan*, T. Khan, and JK. Park Production of bacterial cellulose in static conditions by a simple fed-batch cultivation strategy. (*Co-author)

 

Korean Journal of Chemical Engineering, Korean J. Chem. Eng., 26(6), 1689-1692 (Korea)

2009

3.146

89.  J. K. Park, O. Shehzad, T. Khan, Salman Khan*. Production of bacterial cellulose by G.hasenii using a new bioreactor equipped with centrifugal impellers. (*Co-author)

 

Journal of Biotechnology, 136S, S460–S495. (USA)

2008

3.595

90.  T. Khan, Salman Khan*, J. K. Park. Simple fed-batch cultivation strategy for the enhanced production of single-sugar glucuronic acid-based oligosaccharides by a cellulose-producing Gluconacetobacter strain. (*Co-author)

 

Biotechnology and Bioprocess Engineering, 13, 240-247. (Korea)

2008

3.386

91.  J. H. Ha, O. Shehzad, Salman Khan*, S.Y. Lee, J. W. Park, T. Khan, J.K. Park. Production of bacterial cellulose by a static cultivation using the waste from beer culture broth, Production of bacterial cellulose by a static cultivation using the waste from beer culture broth. (*Co-author)

 

Korean Journal of Chemical Engineering. 25(4), 812-815.

2008

3.146

 

 

 


 

PUBLICATIONS (NON-SCI)

 

Author (s), title

Journal, Vol. No., Page No., Country

Year

Impact factor

1.     A Mustafa, H Ali, R Bibi, A Hassan, Salman Khan*, SA Khan. Simultaneous Determination of Amoxicillin, Clarithromycin and Esomeprazole in Mice Plasma after Oral Administration by Reverse Phase HPLC Method. (*Co-author)

Journal of Chromatography

and Separation Techniques. Vol.12 Iss.1 No:439

2021

00

2.     F Shahid, M Ismail, Salman Khan*. Assessment of quality of life in post-burn survivors: A cross-sectional single-center first validation study from Pakistan. (*Corresponding author)

Burns Open, 2 (1), 35-42. (USA)

 

2018

00

3.     Salman Khan* and Y. S. Kim. Molecular mechanism of inflammatory signaling and predominant role of Saposhnikovia divaricata as anti-inflammatory potential. (*1st author)

Natural Product Sciences, 19(2): 1-7. (Korea)

2013

00

4.     Salman Khan*, A. Shehzad, O. Shehzad, and E. A Al-Suhaimi. Inpatient antibiotics pharmacology and physiological use in Hayatabad Medical Complex, Pakistan. (*1st author)

 

International Journal of Physiology, Pathophysiology and Pharmacology, 5(2):120-127). (USA)

2013

00

5.     Salman Khan*, R. J. Choi, Dong-Ung Lee, Y. S. Kim. Sesquiterpenes derivatives isolated from Cyperus rotundus L. inhibits inflammatory signaling mediated by NF-κB pathway.  (*1st author)

Natural Product Sciences, 17(3): 250-255. (Korea)

 

2011

00

 

BOOK CHAPTERS

 

1.     A Khan, B Shal, A Khan, Salman Khan. Martin, Patel, and Preedy - Treatments, Nutraceuticals, Supplements and Herbal Medicine in Neurological Disorders. Chapter 31: The Potential Role of Herbal Medicine & Nutraceuticals in Neuroinflammatory Disorders: A Mechanistic Insight via Multi-Signaling Cascades. Elsevier 2022

2.     M Zeeshan, M Mukhtar, Q Ul Ain, Salman Khan and H Ali. Nanopharmaceuticals: A Boon to the Brain-Targeted Drug Delivery. Pharmaceutical Formulation Design-Recent Practices. DOI: 10.5772/intechopen.83040. 2019. IntechOpen. UK

 

3.     Salman Khan, A. Tosun, YS Kim. Ginsenosides as Food Supplements and their Potential Role in Immunological and Neurodegenerative Disorders. Chapter 31, 10031-WATSON-9780124114623, Bioactive Nutriceuticals and Food Supplements in Neurological and Brain Disease (2015 Elsevier Inc.).

 

4.     A. Tosun, Salman Khan. Antioxidant Actions of Spices and their Phytochemicals on autoimmunity. WATSON-9780124114623, Bioactive Nutriceuticals and Food Supplements in Neurological and Brain Disease (2015 Elsevier Inc.).

 

PATENTS

 

S. N.

Description

Filing Date

App. No.

IPO

1

Tehmina Bibi, Salman Khan. Neuroprotective effects of Honokiol-loaded solid lipid nanoparticles in Diabetes induced                                     Depression

25/02/20223

53/2023

Pakistan

2

Tehmina Bibi, Salman Khan Attenuation of Diabetes by Honokiol-loaded solid lipid nanoparticles

25/02/2023

54/2023

Pakistan

3

Tehmina Bibi, Salman Khan Ameliorative effects of Honokiol-loaded solid lipid nanoparticles in Diabetic Neuropathy 

25/02/2023

55/2023

Pakistan

4

Ihsan ul Haq, Salman Khan, Bushra Shal, Madiha Ahmed, Bushra Mirza, Tofeeq-Ur-Rehman (2021) Coagulansin-A attenuates pathology of Alzheimer’s disease

05-03-2021

192/2021

Pakistan

5

Ihsan ul Haq, Salman Khan, Adnan Khan, Muhammad Waleed Baig, Madiha Ahmed, Bushra Mirza, Humaira Fatima (2021) Wthametelin ameliorates neuropathogenesis of multiple sclerosis

19-03-2021

222/2021

Pakistan

6

Ihsan ul Haq, Salman Khan, Adnan Khan, Muhammad Waleed Baig, Madiha Ahmed, Bushra Mirza, Humaira Fatima (2021) Wthametelin alleviates neuropathic pain

27-04-2021

322/2021

Pakistan

7

Ihsan ul Haq, Salman Khan, Bushra Shal, Bushra Mirza, Tofeeq-Ur-Rehman (2021) Bergenin attenuates spatial memory deficit

27-04-2021

324/2021

Pakistan


PRESENTATIONS/CONFERENCES/WORKSHOPS

 

i). Conferences

 

ORAL PRESENTATIONS/INVITED SPEAKERS/PLENARY LECTURES

1.     Salman Khan. Capilalrisin, a naturally isolated compound for the treatment of inflammation and pain. International Conference on Emerging Trends in Pharmaceutical Sciences, Capital University of Science and Technology Islamabad Pakistan, March 11, 2023.

2.     Salman Khan. Drug discovery from naturally isolated compounds. International conference on drug discovery and development. MARCH 03, 2022 | WEBINAR, London, UK.

3.     Salman Khan. Therapeutic potential of Poncirus trifoliata. Online Meeting on Phytomedicine and Phytochemistry (February 01-02, 2021), United Scientific Group (USG) USA

4.     Salman Khan. Pain and Nanoparticles: molecular targets and mechanism. Fall International Convention of Pharmaceutical Society of Korea 21-23 October-2020, Korea {Virtual}.

5.     Salman Khan. Vascular dysfunction and potential role of anti-inflammation in
neuropathic pain. 6th Annual Neuroscience Conference (6ANC) {Virtual}Agha Khan University, Saturday October 17, 2020, Karachi.

6.     Salman Khan. Pharmacological evaluations and drug discovery from naturally isolated compound. 1st National Conference on Current Updates in Pharmacy Profession and Research, July 29~30, 2019, COMSATS University Abbottabad, Pakistan.

7.     Salman Khan. Pharmacological Mechanism Underlying Anti-inflammatory, Anti-nociceptive and Neuroprotective Activities of Anomalin. 3rd International conference Recent Advancement in Pharmaceutical Research and Drug Delivery, February 19~20, 2019. QAU, Islamabad, Pakistan.   

8.     Salman Khan. Approach toward new drug development based on pharmacological evaluation from naturally isolated compounds. Proceeding of the 47th Annual Meeting of the Korean Society of Pharmacognosy, The 10th KSP-JSP-CJP joint symposium, Ehwa Women University, Seoul, December 22-23, 2018, South Korea

9.     Salman Khan. Predominant role of vascular dysfunction and potential of anti-inflammation in alleviation of neuropathic pain. Asia PharmII (The 2nd Asian conference of Pharmaceutical Sciences, Jun 2-22, 2017, Seoul, Korea.

10.  Salman Khan, RJ Choi, JH Lee, YS Kim. Attenuation of neuropathic pain and neuroinflammatory responses by a pyranocoumarin derivative, anomalin in animal and cellular models. Proceeding of the 46th Annual Meeting of the Korean Society of Pharmacognosy, Seoul, December 03, 2015, South Korea.

11.  Salman Khan, R. J. Choi, O. Shehzad, H. P. Kim, M. N. Islam, J. S. Choi, and Y. S. Kim. Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signaling and its anti-hyperalgesic effect in an inflammatory pain models. 11th CGCM meeting, August 20~24, 2012, Macau. 

12.  Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, A. Tosun, Y. Shik Kim. Anomalin, pyranocoumarin inhibits LPS-induced expression of inflammatory mediators via NF-κB and MAP-kinase signaling pathways. 10th CGCM meeting August 26~ 28, 2011, Shanghai, China.

13.  Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, Y. Shik Kim. Suppression of LPS-induced inflammatory and NF-κB responses by anomalin isolated from the root of Saphoshnikovia divaricata in RAW 264.7 macrophages. December 22-24, 2010 (Tokoshima), Japan.

14.  Salman Khan, E. M. Shin, D-U. Lee, Y. S. Kim. Bioactivity guided evaluation of sesquiterpenes as an anti-inflammatory activity isolated from Cyperus rotundus L: Effect of chemical structures and cellular signaling pathway. 9th CGCM meeting, 2010. Hong Kong.

 

POSTER PRESENTATIONS/ CONFERENCES

 

1.     Salman Khan. NAPRECA - COMSTECH Summer School. Theme “Phytomedicine - from the bush to the shelf” Online and at the Confucius Institute, University of Nairobi, Nairobi, Kenya, 31st October~4th November 2022.  

2.     Salman Khan. Virtual Drug Discovery Symposium 2022, LUMS, September 16, 2022, Lahore Pakistan

3.     Salman Khan. “Measuring Pain Outcomes” – Pain360 Webinar, 4rth March, 2022, Central Europe.

4.     Salman Khan. webinar on “NRF2 and Cancer” Thursday, 3rd March 2022, Italy.

5.     Salman Khan. COMSTECH online course entitled "Protozoan ’Drug’ Discovery: Old Drugs, New Targets and Mining for Novelty, Delivered by Prof. Dr. Paul W. Denny, August 6th, 2021, Islamabad, Pakistan.

6.     Salman Khan. COMSTECH webinar “Online Meeting on Recent Developments in Drug Discovery and Medicinal Chemistry" on July 26-27, 2021, Islamabad, Pakistan.

7.     Salman Khan. 2nd Global Virtual Conference on Neurodegenerative Diseases (GVCND-2021). Central European (Berlin, Rome, Stockholm, Vienna) January 28, 2021.

8.     B Shal, A Khan, A Ullah Khan, Salman Khan. Neuroprotective effect of a triterpenoid derivative against CCl 4 -induced behavior alterations by targeting VEGF/BDNF and caspase-3 in mice. Autumn Meeting for Young Chemists in Biomedical Sciences (AMYC BIOMED) organized by Department of Excellence of Pharmacy (University of Naples Federico II. Italy), Oct 13-14, 2020.

9.     A Khan, B Shal, A Ullah Khan, T Bibi, Salman Khan. Phytosteroid ameliorates the progression of motor/sensory symptoms in a mouse model of multiple sclerosis. Autumn Meeting for Young Chemists in Biomedical Sciences (AMYC BIOMED) organized by Department of Excellence of Pharmacy (University of Naples Federico II, Italy), Oct 13-14, 2020.

10.  Salman Khan. 4th International Conference (Virtual) titled “Integrative multidisciplinary nanomedicine: a game changing strategy for emerging infectious disease” Department of Pharmacy, Quaid-i-Azam University in collaboration with ORIC QAU, Islamabad, Pakistan. October 10, 20120.

11.  B Shal, A Khan, M Naveed, YS Kim, Salman Khan. Anti-anxiety and anti-depressant effect of a triterpenoid derivative against bacteria-induced behavioral alterations. in 6th international conference on Drug Development-Natural and Synthetic: Current approaches and emerging trends for the development and discovery of drugs being hosted by Centre for Advanced Drug Research (CADR), COMSATS University, Abbottabad on Nov 29-30, 2019.

12.  A Ullah Khan, A Muhammad, A Khan, B Shal, MN Ahmad, A Aziz, Salman Khan. The newly synthesized N-Benzylidene-4-(2-HydroxyNaphthalene-1-yl) Diazenyl) Hydrazides (1-2) (NCHDH and NTHDH) compounds attenuates LPS-induced septicemia and multi-organ failure through HSP70/90 proteins and Nrf2 signaling. 6th international conference on Drug Development-Natural and Synthetic: Current approaches and emerging trends for the development and discovery of drugs being hosted by Centre for Advanced Drug Research (CADR), COMSATS University, Abbottabad on Nov 29-30, 2019.

13.  A Khan, B Shal, A Ullah Khan, IU Haq, Salman Khan. Isowithametelin and Ajugarin-1 protects hippocampal neuronal cells against H2O2-induced damage through suppression of oxidative stress. (6th international conference on Drug Development-Natural and Synthetic: Current approaches and emerging trends for the development and discovery of drugs being hosted by Centre for Advanced Drug Research (CADR), COMSATS University, Abbottabad on Nov 29-30, 2019.

14.  A Khan, B Shal, M Naveed, YS Kim, Salman Khan. Anxiolytic and antidepressant-like effects of matrine through inhibition of JNK-mediated inflammatory, ROS, and apoptotic signaling in animal model of burn injury. 3rd International Conference onRecent Advancement in Pharmaceutical Research and Drug Delivery”, Department of Pharmacy, Quaid-i-Azam University, Islamabad on Feb 19-20, 2019.

15.  Salman Khan. International Pharmacy Conference and Exhibition (IPCE), Jun 18~19, 2019, University of Swabi, KPK, Pakistan

16.  Salman Khan. Pharmacological evaluations and drug discovery from naturally isolated compound. 1st National Conference on Current Updates in Pharmacy Profession and Research, July 29~30, 2019 COMSATS University Abbottabad, Pakistan.  

17.  S Khalid, M Ziaullah, A Khan, R Afridi, h Rasheed, A Khan, H Ali, YS Kim, Salman Khan. Antihyperalgesic and antiallodynic properties of honokiol in acute and chronic models of inflammatory pain. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

18.  A Khan, M Ziaullah, R Afridi, H Rasheed, S Khalid, H Ullah, YS Kim, Salman Khan. Anti-nociceptive properties of 25-MHA in CFA and carrageenan-induced in animal models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan

19.  H Rasheed, R Afridi, A Khan, M Ziaullah, S Khalid, A Atiq, H kashif, MN Ahmad, YS kim, Salman Khan. Anti‑infammatory and analgesic activities of 2‑(5‑me rcapto‑1,3,4‑oxadiazol‑2‑yl)‑N‑propylbenzenesulphonamide (MOPBS) in rodents. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

20.  A Atiq, B Shal, M Naveed, A Khan, S Zeeshan, Salman Khan. Pharmacological evaluation of Silver sulfadiazine nanoparticles loaded Alovera encapsulated film on animal mode of wounds. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

21.  M Naveed, S Zeeshan, A Khan, B Shal, A Atiq, Salman Khan. Anti-inflammatory, analgesic and antipyretic activities of newly synthesized hetroleptic palladium (II) complexes. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

22.  S Zeeshan, M Naveed, A Khan, B Shal, H Rasheed, Salman Khan. Anti-inflamamtory and analgesic effect of novel palladium (II) complexes on animal models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan

23.   A Khan, B Shal, M Naveed, A Atiq, S Zeeshan, Salman Khan. Matrine ameliorates anxiety and depressive like behavior in carbon tetrachloride and burn-induced animal models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

24.   B Shal, A Khan, M Naveed, A Atiq, S Zeeshan, Salman Khan. Evaluation of pharmacological potential of 25-MHA in LPS and CCl4-induced anxiety and depression models. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

25.  R Afridi, H Rasheed, A Khan, S Khalid, Z ullah, B Shal, H Jabeen, YS Kim, Salman Khan. Antihyperalgesic properties of Flavone derivative Poncirin in acute and chronic inflammatory pain models in mice. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

26.   M Zeeshan, H Ali, M Arshad, MI Khan, M Mukhtar, Salman Khan. Design. Characterization and kinetics study of Glycyrrhizic acid loaded pH-sensitive PLGA nanoparticles for the potential drug targeting in inflammatory bowel disease. 1st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan

27.  Salman Khan. 2nd international conference on recent innovations in pharmaceutical sciences (ICRIPS-2017), Organized by Riphah Institute of Pharmaceutical Sciences, November 15-16, 2017, Islamabad, Pakistan.

28.  Salman Khan, O. Shehzad, J. Chun, and Y. S. Kim. Mechanism underlying anti-hyperalgesic and anti-allodynic properties of anomalin in both acute and chronic inflammatory pain models in mice through inhibition of NF-κB, CREB and MAPKs signaling cascades. Korean Society of Pharamcognosy 2012. 06. (Seoul, Korea).

29.  Salman Khan, R. J. Choi, O. Shehzad, H. P. Kim, M. N. Islam, J. S. Choi, and Y. S. Kim. Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signaling and its anti-hyperalgesic effect in an inflammatory pain models. 11th CGCM meeting August 20~24, 2012, Macau. 

30.  Salman Khan, E. M. Shin, S. W. Baek, J. Kim, Y. S. Kim. Novel labdan diterpene derivative isolated from Leonurus japonicum as a function of anti-inflammatory activity in LPS-stimulated RAW 264.7 cells. 9th CGCM meeting, 2010, Hong Kong.

31.  Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, Y. S. Kim. Anti-inflammatory and anti-NF-κB effects of anomalin isolated from the root of Saposhnikovia divaricata in LPS-stimulated RAW264.7 macrophages.  9th CGCM meeting, 2010, Hong Kong.

32.  Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, Y. Shik Kim. Suppression of LPS-induced inflammatory and NF-κB responses by anomalin isolated from the root of Saphoshnikovia divaricata in RAW 264.7 macrophages. December 22-24, 2010 (Tokoshima), Japan.

33.  Salman Khan, O. Shehzad, T. Khan, J. K. Park, Investigation of flow pattern and volumetric oxygen transfer coefficient (KLa) for new bioreactors equipped with centrifugal impellers. Korean Society of Biotechnology and Bioprocess engineering (KSBB), 2008, Jinju S. Korea

34.  Salman Khan, O. Shehzad, T. Khan, J. K. Park, Treatment of Brewery Waste for the Improved Production of Bacterial Cellulose by a Gluconacetobacter Strain, Young Asian Biochemical Engineers’s Community 2007, (YABEC), Japan.

35.  Salman Khan, O. Shehzad, T. Khan, J. K. Park, Evaluation of Autolyzed waste of beer fermentation broth as a basal medium for the production of bacterial cellulose and oligosaccharides Gluconacetobacter hansenii, Korean Institute of Chemical Engineers 2007 (KIChE-2007), Daejon, South Korea.

36.  Salman Khan, O. Shehzad, T. Khan, J. K. Park, Production and structure feature of bacterial cellulose using nano-bubble system, Young Asian Biochemical Engineers’s Community 2008 (YABEC-2008), Japan.

37.  Salman Khan, O. Shehzad, T. Khan, J. K. Park, Production of bacterial cellulose using waste from beer fermentation broth in shaking cultivation, Korean Society of Biotechnology and Bioprocess engineering (KSBB), 2008, Jeju do, S.Korea.

38.   O. Shehzad, Salman Khan, T. Khan, J. K. Park, Production of Bacterial Cellulose membrane by G. hasenii using fed batch cultivation. (Korean Society of Biotechnology and Bioprocess engineering (KSBB), 2008, Jinju S. Korea.

39.  O. Shehzad, Salman Khan, T. Khan, J. K. Park, Production of bacterial cellulose in fed batch cultivation using waste from beer fermentation broth. Korean Institute of Chemical Engineers (KIChE-2008), Pusan, Oct 22, 2008, South Korea.

40.  O. Shehzad, Salman Khan, T. Khan, J. K. Park, Physico-Chemico-Mechanical characteristics of bacterial cellulose produced in fed batch cultivation using waste from beer fermentation broth. Korean Institute of Chemical Engineers (KIChE-2008), Pusan, Oct 22, 2008, South Korea.

 

ii. Courses and Workshops/Trainings

 

1.     3-days national workshop on “Nanomedicine”: Advancement & Challenges in Pakistan. Organized by HEC-QAU, November 27-29, 2017.

2.     “Nanomedicine: Novel Approaches in Drug Delivery”. at Kohat University of Science and Technology, Kohat, Pakistan, 11-12 April 2017.

3.     Integrated clinical pharmacy education, practice & Research: Bridging the Gap- Organized by COMSTECH from 22-24 Feb 2016.

4.     3-day workshop on “Teaching and Research Skills” Organized by HEC-QAU, October 18-20, 2016.

S.No

Title

Role

Amount

Duration

Status

Funding agency

1.

Joint Project between College of Pharmacy, Ewha Woman University, Korea and Department of Pharmacy, Quaid-i-Azam University, Islamabad

EK Seo, Korea and Salman Khan, PI, Pakistan

32000USD

October 25, 2021~ October 25, 2024

Ongoing

NRF, Korea

2.

National Research Fund by HEC Preparation and characterization of tofacitinib loaded pH-sensitive PLGA-nanoparticles for the treatment of inflammatory bowel diseases

Hussain Ali-PI, Salman Khan- Co-PI

2.82 million rupees

September 2019~September 2022

Ongoing

HEC

3.

Joint Project between College of Pharmacy, Seoul National University, Korea and Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan

YSK, SNU Korean and Salman Khan, PI, Pakistan

40000 USD

2015

Completed

NRF, Korea

4.

Neuroinflammation Training Program

Z Zhang, PI and Salman Khan PI

40000USD

2015

Completed

CIHR, Canada

5.

BK-21-plus research grant

Salman Khan, PI

30000USA

2013-2014

Completed

BK-21-plus, College of Pharmacy, Seoul National University, Seoul, South Korea

6.

Start-up Project (SRGP) Approved by

Salman Khan PI, GM Khan Co-PI

500000 PRS

2015

Completed

Higher Education Commission (HEC) of Pakistan



Quaid-i-Azam University Islamabad, 45320, Pakistan.
Tel: +92-51 9064 0000, Email:webmaster@qau.edu.pk